Point72 Asset
View Older Stories View More Recent Stories
-
Cohen Veterans Network Marks a Decade of Innovation, Filling Mental Health Care Gaps for Post-9/11 Veterans, Service Members and Their Families
-
NeOnc Technologies secures $16 million PIPE investment led by Cinctive
-
NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management
-
Cohen Veterans Network Partners with the Gary Sinise Foundation to Extend Its Proven Model of Mental Health Care to Serve Los Angeles Fire Department (LAFD) Uniformed Personnel and Their Families
-
Form SCHEDULE 13G PRECIGEN, INC. Filed by: Point72 Asset Management, L.P.
-
New Research from Cohen Veterans Network Aims to Identify Optimal Messaging for Lethal Means Safety Among Veterans
-
Apolo V Acquisition Corp. Enters into Definitive Agreement with Telyrx, Inc.
-
Form SCHEDULE 13G Infinite Eagle Acquisiti Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Forte Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
-
Cohen Veterans Network Announces Its First Mental Health Clinic in Kansas in Collaboration with the Robert R. McCormick Foundation to Treat Service Members, Veterans and Their Families Across the Stat
-
Strong year for hedge funds drives big gains for Wall Street's prime brokerage engine
-
Darkroom Names Former Rokt VP Peter Gao as SVP of Growth as the Agency Targets Industry-Shaping Brands
-
Form SCHEDULE 13G/A KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G VNET Group, Inc. Filed by: Point72 Asset Management, L.P.
-
Water Tower Research (WTR) Adds Eric Goldstein as Managing Director – Mobility
-
Hedge funds rode buoyant stock market to deliver double-digit gains in 2025, Goldman Sachs says
-
Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Century Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
-
Factbox-Top hedge funds led by D.E.Shaw, Bridgewater and Balyasny deliver big gains in 2025
-
Point72 reports 9.2% passive stake in Tonix Pharma (TNXP)
-
Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
CookUnity and New York Golf Club Announce Partnership to Elevate the Meals of the Next Generation of Golfers
-
The Sohn Conference Foundation Announces 2026 Global Events Calendar and Initial Sponsor Commitments
-
Larry Mastropieri: Delray Beach’s Luxury Market Is Outpacing Coastal Competition – Rewriting The Luxury Playbook
-
Larry Mastropieri: Delray Beach’s Downtown Strategy – What Developers and Investors Are Missing
-
Bevel Founder Jessica Schaefer Returns with Capital V, A Modern Approach to Strategic Communications
-
New York Gaming Commission Approves Metropolitan Park for Gaming License
-
Cohen Veterans Network Expands Internationally, Launching Mental Health Clinics in Asia for U.S. Military Families Stationed Abroad Alongside the Army & Air Force Exchange Service (AAFES)
-
Bally's Corporation (BALY) shares soar on NYC casino win
-
Steve Cohen, Bally's, Genting Group to run NYC casinos
-
Form SCHEDULE 13G BILL Holdings, Inc. Filed by: Point72 Asset Management, L.P.
-
Hedgeye Asset Management Launches the Hedgeye Fourth Turning ETF (HEFT) Co-Managed by Neil Howe and R. Patrick Kent
-
BitMine engages Tom DeMark as strategic advisor for ETH strategy
-
BitMine (BMNR) Engages Legendary Tom DeMark and DeMark Analytics, LLC as Strategic Advisor
-
Form 13F-HR Point72 Asset Management For: Sep 30
-
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A CYBIN INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Confluent, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Turnstone Biologics Corp Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Mobileye Global Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A PepGen Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A FG Nexus Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Replimune Group, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Zepp Health Corp Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: Point72 Asset Management, L.P.
